Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards.
[tabs style="vertical"] [tab title="Sponsored research"]John A. Bartlett of Infectious Diseases has received a sub-award (ACTG A5280) through the Social & Scientific Systems, Inc. for a project entitled "A5280 Additional Funds BRS-ACURE-S- 12-002209." Total funding will be $1,500.
John A. Bartlett of Infectious Diseases has received a sub-award (ACTG A5303) through the Social & Scientific Systems, Inc. for a project entitled "BRS-ACURE-S-12-002354 A5303." Total funding will be $4,640.
John A. Bartlett of Infectious Diseases has received a sub-award (UM1-AI068363-06) through the Social & Scientific Systems, Inc. for a project entitled "BRS-ACURE-S-11-000056-002062 A5272." Total funding will be $24,695.
Vance G. Fowler Jr. of Infectious Diseases has received an award (2R01-AI068804-06A1) from the National Institutes of Health for a project entitled "Host Susceptibility to S. aureus." Total funding will be $3,531,373.
Laura Musselwhite (Mentor: Nathan M. Thielman) of Infectious Diseases has received an award from the American Medical Association Foundation for a project entitled "Evaluation of Vitamin D as a Predictor of Immune Reconstitution Inflammatory Syndrome in AIDS Patients Initiating Antiretroviral Therapy in South Africa and Mexico." Total funding will be $2,500.
Nicole Calakos of Neurology has received an award from the Dystonia Medical Research Foundation for a project entitled "Comprehensive examination of motor circuit activity in awake behaving DYT1 knockin mice." Total funding will be $128,652.
Burton L. Scott of Neurology has received an award from the CHDI Foundation for a project entitled "Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort (A CHDI Foundation Project)." Total funding will be $94,711.
Robert M. Tighe of Pulmonary, Allergy & Critical Care Medicine has received an award (1K08-HL105537-01A1) from the National Institutes of Health for a project entitled "Regulation of Lung Fibrosis by Alternatively Activated Macrophages and Arginase-1." Total funding will be $453,015.[/tab] [tab title="Industry-sponsored clinical trials"]Christopher Granger of Cardiology has received an award from Pfizer, Inc. for a project entitled "Medication Adherence Alliance." Total funding will be $50,000.
Robert J. Noveck of Cardiology has received an award from Isis Pharmaceuticals for a project entitled "Phase 1 study to assess treatment of ISIS 329993." Total funding will be $895,480.
Keyur Patel of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Investigate the Efficacy and Safety of GS-7977 + Ribavirin for 12 Weeks." Total funding will be $131,484.
Vance G. Fowler Jr. of Infectious Diseases has received an award from MedImmune, Inc. for a project entitled "Duke Staph Aureus Collaboration Project." Total funding will be $303,804.
Daniel Laskowitz of Neurology has received an award from Scion NeuroStim LLC for a project entitled "Effect of Vestibular Stimulation on Cerebral Blood Flow in Normal Subjects." Total funding will be $18,906.
Mark A. Stacy of Neurology has received an award from Medtronic, Inc. for a project entitled "Duke Parkinson's Disease and Movement Disorders Fellowship Program." Total funding will be $25,000.
Herbert I. Hurwitz of Medical Oncology has received an award from Morphotek, Inc for a project entitled "A randomized double blinded placebo-controlled study of the efficacy and safety of monotherapy MORAb-004 plus best supportive care in subjects with chemorefractory metastatic colorectal cancer." Total funding will be $131,484.
P. Kelly Marcom of Medical Oncology has received an award from Abbott Laboratories for a project entitled "A Randomized, Phase 2 Study of the Efficacy & Tolerability of Veliparib in Comb w Temozolomide or Veliparib in Comb w Carboplatin & Paclitaxel Versus Placebo + Carboplatin & Paclitaxel in Subjects w BRCA1 or BRCA2 Mutation & Metastatic Breast Cancer." Total funding will be $217,275.
Andrew B. Nixon of Oncology has received an award from Bristol-Myers Squibb for a project entitled "IGFR axis and BMS 754807 in colorectal cancer: preclinical models and pathology asssay development and testing." Total funding will be $295,000.
Richard F. Riedel of Medical Oncology has received an award from GlaxoSmithKline for a project entitled "A Phase I/II open-label study of eltrombopag for the prevention of chemotherapy induced thrombocytopenia (CIT) in subjects with advanced soft tissue and bone sarcomas receiving gemcitabine and docetaxel chemotherapy." Total funding will be $802,551.
April K. Salama of Medical Oncology has received an award from Bristol-Myers Squibb for a project entitled "A Randomized Double-Blind Phase III Study of Ipilimumab Administration at 3 mg/kg vs at 10 mg/kg in Subjects with Previously Treated or Untreatreated Unresectable or Metastatic Melanoma." Total funding will be $103,649.
John H. Strickler of Medical Oncology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 2 randomized double blinded placebo controlled study to ebaluate the efficacy and safety of GS-6624 combined with Gemcitabine as first line treatment for maetastatic pancreatic andemocarcinoma." Total funding will be $241,357.
James J. Vredenburgh of Medical Oncology has received an award from Celldex Therapeutics, Inc. for a project entitled "International, randomized, double-blind, controlled study of Rindopepimut/GM-CSF with adjuvant temozolomide in patients with newly diagnosed, surgically resected, EGFRvIII-positive GBM (ACT IV)." Total funding will be $324,618.[/tab] [/tabs]